Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
On
April 04, 2022, AgeX borrowed an additional $1 million under the Secured Convertible Promissory Note (the “Secured Note”)
dated as of February 14, 2022 with Juvenescence Limited (“Juvenescence”). AgeX has now borrowed $9,160,000 of the line of
credit under the Secured Note. The remaining $4 million of the line of credit may be drawn down from time to time through the first anniversary
date subject to Juvenescence’s discretion to approve each loan draw. AgeX may not draw more than $1 million in any subsequent single
draw. The outstanding principal balance of the Secured Note will become due and payable on February 14, 2024 (the “Repayment Date”).
In
lieu of accrued interest, AgeX will pay Juvenescence an Origination Fee in an amount equal to 4% of the amount each draw of loan funds,
which will accrue as each draw is funded, and an additional 4% of all the total amount of funds drawn that will accrue following the
end of the 12 month period during which funds may be drawn from the line of credit. The Origination Fee will become due and payable on
the Repayment Date or in a pro rata amount with any prepayment of in whole or in part of the outstanding principal balance of the Secured
Note.
The
Outstanding Amount may become immediately due and payable prior to the Repayment Date if an Event of Default as defined in the Secured
Note occurs. Events of Default under the Secured Note include: (a) AgeX fails to pay any principal amount payable by it in the manner
and at the time provided under and in accordance with the Secured Note, (b) AgeX fails to pay any other amount payable by it in the manner
and at the time provided under and in accordance with the Secured Note or the Security Agreement described below or any other agreement
executed in connection with the Secured Note (the “Other Loan Documents”) and the failure is not remedied within three business
days; (c) AgeX fails to perform any of its covenants or obligations or fail to satisfy any of the conditions under the Secured Note or
any other Loan Document and, such failure (if capable of remedy) remains unremedied to the satisfaction of Juvenescence (in its sole
discretion) for 10 business days after the earlier of (i) notice requiring its remedy has been given by Juvenescence to AgeX and (ii)
actual knowledge of the failure by senior officers of AgeX; (d) if any indebtedness of AgeX in excess of $100,000 becomes due and payable,
or a breach or other circumstance arises thereunder such that Juvenescence is entitled to declare such indebtedness due and payable,
prior to its due date, or any indebtedness of AgeX in excess of $25,000 is not paid on its due date; (e) AgeX stops payment of its debts
generally or ceases or threatens to cease to carry on its business or is unable to pay its debts as they fall due or is deemed by a court
of competent jurisdiction to be unable to pay its debts as they fall due, or enters into any arrangements with its creditors generally;
(f) if (i) an involuntary proceeding (other than a proceeding instituted by Juvenescence or an affiliate of Juvenescence) shall be commenced
or an involuntary petition shall be filed seeking liquidation, reorganization or other relief in respect of AgeX and any subsidiary,
or of all or a substantial part of its assets, under any federal, state or foreign bankruptcy, insolvency, receivership or similar law
now or hereafter in effect or (ii) an involuntary appointment of a receiver, trustee, custodian, sequestrator, conservator or similar
official for AgeX or a subsidiary or for a substantial part of its assets occurs (other than in a proceeding instituted by Juvenescence
or an affiliate of Juvenescence), and, in any such case, such proceeding shall continue undismissed and unstayed for sixty (60) consecutive
days without having been dismissed, bonded or discharged or an order of relief is entered in any such proceeding; (g) it becomes unlawful
for AgeX to perform all or any of its obligations under the Secured Note or any authorization, approval, consent, license, exemption,
filing, registration or other requirement of any governmental, judicial or public body or authority necessary to enable AgeX to comply
with its obligations under the Secured Note or to carry on its business is not obtained or, having been obtained, is modified in a manner
that precludes AgeX or its subsidiaries from conducting their business in any material respect, or is revoked, suspended, withdrawn or
withheld or fails to remain in full force and effect; (h) the issuance or levy of any judgment, writ, warrant of attachment or execution
or similar process against all or any material part of the property or assets of AgeX or a subsidiary if such process is not released,
vacated or fully bonded within 60 calendar days after its issue or levy; (i) any injunction, order, judgment or decision of any court
is entered or issued which, in the opinion of Juvenescence, materially and adversely affects, or is reasonably likely so to affect, the
ability of AgeX or a subsidiary to carry on its business or to pay amounts owed to Juvenescence under the Secured Note; (j) AgeX, whether
in a single transaction or a series of related transactions, sells, leases, licenses, consigns, transfers or otherwise disposes of any
material portion of its assets (with any such disposition with respect to any asset or assets with a fair value of at least $250,000
being deemed material), other than (i) certain permitted investments (ii) sales, transfers and dispositions of inventory in the ordinary
course of business, (iii) any termination of a lease of real or personal property that is not necessary in the ordinary course of the
AgeX’s business, could not reasonably be expected to have a material adverse effect and does not result from AgeX’s
default, and (iv) any sale, lease, license, consignment, transfer or other disposition of assets that are no longer necessary in the
ordinary course of business or which has been approved in writing by Juvenescence; (k) any of the following shall occur: (i) the security
and/or liens created by the Security Agreement or any other Loan Document shall at any time cease to constitute valid and perfected security
and/or liens on any material portion of the collateral intended to be covered thereby; (ii) except for expiration in accordance with
its terms, the Security Agreement or any other Loan Document pursuant to which a lien is granted by AgeX in favor of Juvenescence shall
for whatever reason be terminated or shall cease to be in full force and effect; (iii) the enforceability of the Security Agreement or
any other Loan Document pursuant to which a lien is granted by AgeX in favor of Juvenescence shall be contested by AgeX or a subsidiary,
(iv) AgeX shall assert that its obligations under the Secured Note or any other Loan Document shall be invalid or unenforceable, or (v)
a loss, theft, damage or destruction occurs with respect to a material portion of the collateral; (l) there is any change in the financial
condition of AgeX and its subsidiaries which, in the opinion of Juvenescence, materially and adversely affects, or is reasonably likely
so to affect, the ability of AgeX to perform any of its obligations under the Secured Note; and (m) any representation, warranty or statement
made, repeated or deemed made or repeated by AgeX in the Secured Note, or pursuant to the Loan Documents, is incomplete, untrue, incorrect
or misleading in any material respect when made, repeated or deemed made.